Rethinking Obesity in Heart Failure Module

CME

Rethinking Obesity Management in Heart Failure: The Evolving Treatment Landscape

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit

Released: May 02, 2025

Expiration: May 01, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

A patient newly diagnosed with HFpEF has concurrent obesity. Which of the following would be best to tell the patient?

2.

You are aiming to develop a comprehensive treatment plan with shared decision-making for a patient with HFpEF and BMI 32 kg/m2. What is the most appropriate initial approach to guide the patient toward effective weight management?

3.

A 65-year-old female patient with HFpEF and BMI 35 kg/m2 is struggling to lose weight. She has shortness of breath during exertion and persistent fatigue and asks if she should start a GIP/GLP-1 coagonist or GLP-1 RA to help with weight loss. Which of the following is true regarding recent pharmacologic efficacy and safety data for patients with HF and obesity?